<DOC>
	<DOCNO>NCT00842153</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Clobetasol propionate Vehicle treatment mild moderate plaque-type psoriasis .</brief_summary>
	<brief_title>Evaluation Efficacy Tolerability Clobetasol Propionate Foam Compared Vehicle Foam</brief_title>
	<detailed_description>The purpose study compare efficacy safety Clobetasol propionate Vehicle treatment mild moderate plaque-type psoriasis . This multi-center , double blind , randomize , parallel design study consist 2 week treatment follow-up visit 2 week later .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Outpatient , male female race , least 12 year age . Female subject childbearing potential must negative urine pregnancy test result baseline practice reliable method contraception throughout study . Mild moderate , plaquetype psoriasis Target lesion trunk extremity ( exclude palms/soles , elbow , knee ) score 2 3 erythema , scale plaque thickness Able understand requirement study sign Informed Consent/HIPAA Authorization Forms . Subjects legal age consent state study conduct must also write , informed consent parent legal guardian . Female subject pregnant ( positive urine pregnancy test ) breast feed childbearing potential practicing reliable method birth control Known allergy clobetasol propionate topical corticosteroid ; component investigational formulation Subjects comply proper washout period prohibit medication Medical condition opinion investigator , contraindicate subject 's participation clinical study Skin disease/disorder might interfere study related diagnosis evaluation Evidence recent alcohol drug abuse History poor cooperation , noncompliance medical treatment unreliability</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Plaque Type Psoriasis</keyword>
</DOC>